222 related articles for article (PubMed ID: 29716829)
1. Checkpoints and beyond - Immunotherapy in colorectal cancer.
Gutting T; Burgermeister E; Härtel N; Ebert MP
Semin Cancer Biol; 2019 Apr; 55():78-89. PubMed ID: 29716829
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for colorectal cancer.
Koido S; Ohkusa T; Homma S; Namiki Y; Takakura K; Saito K; Ito Z; Kobayashi H; Kajihara M; Uchiyama K; Arihiro S; Arakawa H; Okamoto M; Gong J; Tajiri H
World J Gastroenterol; 2013 Dec; 19(46):8531-42. PubMed ID: 24379570
[TBL] [Abstract][Full Text] [Related]
3. Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines.
Vreeland TJ; Clifton GT; Herbert GS; Hale DF; Jackson DO; Berry JS; Peoples GE
Expert Rev Clin Immunol; 2016 Dec; 12(12):1347-1357. PubMed ID: 27323245
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for metastatic colorectal cancer: present status and new options.
Ellebaek E; Andersen MH; Svane IM; Straten PT
Scand J Gastroenterol; 2012 Mar; 47(3):315-24. PubMed ID: 22214467
[TBL] [Abstract][Full Text] [Related]
5. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
Guo L; Wang C; Qiu X; Pu X; Chang P
Front Immunol; 2020; 11():1052. PubMed ID: 32547556
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
[TBL] [Abstract][Full Text] [Related]
7. Results and challenges of immune checkpoint inhibitors in colorectal cancer.
Emambux S; Tachon G; Junca A; Tougeron D
Expert Opin Biol Ther; 2018 May; 18(5):561-573. PubMed ID: 29471676
[TBL] [Abstract][Full Text] [Related]
8. T-cell-based immunotherapy in colorectal cancer.
Feng M; Zhao Z; Yang M; Ji J; Zhu D
Cancer Lett; 2021 Feb; 498():201-209. PubMed ID: 33129958
[TBL] [Abstract][Full Text] [Related]
9. An update on colorectal cancer microenvironment, epigenetic and immunotherapy.
Jin K; Ren C; Liu Y; Lan H; Wang Z
Int Immunopharmacol; 2020 Dec; 89(Pt A):107041. PubMed ID: 33045561
[TBL] [Abstract][Full Text] [Related]
10. [Immune response and colorectal cancer].
Tougeron D; Fauquembergue E; Latouche JB
Bull Cancer; 2013 Mar; 100(3):283-94. PubMed ID: 23501583
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of Colorectal Cancer.
Jäger D; Halama N; Zörnig I; Klug P; Krauss J; Haag GM
Oncol Res Treat; 2016; 39(6):346-50. PubMed ID: 27259331
[TBL] [Abstract][Full Text] [Related]
12. Adoptive T-Cell Therapy for Cancer.
Yang JC; Rosenberg SA
Adv Immunol; 2016; 130():279-94. PubMed ID: 26923004
[TBL] [Abstract][Full Text] [Related]
13. Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
Ascierto PA; Agarwala SS; Ciliberto G; Demaria S; Dummer R; Duong CPM; Ferrone S; Formenti SC; Garbe C; Halaban R; Khleif S; Luke JJ; Mir LM; Overwijk WW; Postow M; Puzanov I; Sondel P; Taube JM; Thor Straten P; Stroncek DF; Wargo JA; Zarour H; Thurin M
J Transl Med; 2017 Nov; 15(1):236. PubMed ID: 29145885
[TBL] [Abstract][Full Text] [Related]
14. Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer.
Hope C; Emmerich PB; Papadas A; Pagenkopf A; Matkowskyj KA; Van De Hey DR; Payne SN; Clipson L; Callander NS; Hematti P; Miyamoto S; Johnson MG; Deming DA; Asimakopoulos F
J Immunol; 2017 Sep; 199(5):1933-1941. PubMed ID: 28754680
[TBL] [Abstract][Full Text] [Related]
15. Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?
Fan J; Shang D; Han B; Song J; Chen H; Yang JM
Theranostics; 2018; 8(20):5784-5800. PubMed ID: 30555581
[TBL] [Abstract][Full Text] [Related]
16. Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.
Berry J; Vreeland T; Trappey A; Hale D; Peace K; Tyler J; Walker A; Brown R; Herbert G; Yi F; Jackson D; Clifton G; Peoples GE
Expert Rev Clin Immunol; 2017 Mar; 13(3):235-245. PubMed ID: 27552944
[TBL] [Abstract][Full Text] [Related]
17. Novel avenues in immunotherapies for colorectal cancer.
Pardieck IN; Jawahier PA; Swets M; van de Velde CJ; Kuppen PJ
Expert Rev Gastroenterol Hepatol; 2016; 10(4):465-80. PubMed ID: 26582071
[TBL] [Abstract][Full Text] [Related]
18. Genomics and emerging biomarkers for immunotherapy of colorectal cancer.
Kather JN; Halama N; Jaeger D
Semin Cancer Biol; 2018 Oct; 52(Pt 2):189-197. PubMed ID: 29501787
[TBL] [Abstract][Full Text] [Related]
19. Developments in immunotherapy for gastrointestinal cancer.
Diaz JL; Wanta SM; Fishbein TM; Kroemer A
Minerva Chir; 2015 Aug; 70(4):217-30. PubMed ID: 25916195
[TBL] [Abstract][Full Text] [Related]
20. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
Lin T; Song C; Chuo DY; Zhang H; Zhao J
Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
